Anna Aillerie


Head Of Commercial Operations, Biotechnology Business Unit
Gedeon Richter
Biosimilars Commercialisation Summit Agenda 2019

Biosimilars Commercialisation Summit Agenda 2019

View Content

Conference Day One

Wednesday, February 5th, 2020


2:05 PM Case Study: Launching a Biosimilar into the European Marketplace in 2019

  • Explore the current European market place by analysing the successes and failures of Big Pharma and SMEs  in their approach to  biosimilar commercialisation 
  • Benchmark your branding practice and commercial strategy against the challenges and opportunities encountered in the preparation for launch of a new biosimilar 
  • Get a sneak peek into pre-marketing and marketing activities around a launch of a new biosimilar into the European market  

5:40 PM Panel Discussion: Boosting Patient Access to Biosimilars In Europe

  • Explore the need for collaboration between Payers, Regulators and Industry to enhance patient access to biosimilars in Europe
  • Consider how policy can be utilized as a tool to broaden patient access
  • What does the future hold for the stability of the Biosimilars Market in the EU?

Check out the incredible speaker line-up to see who will be joining Anna.

Download The Latest Agenda